Current News and Events
Concentrics works with Alcon on successful switch of Pataday
Posted February 24th, 2020. Filed under ArchivesConcentrics works with GSK on successful switch of Voltaren
Posted February 24th, 2020. Filed under ArchivesConcentrics Research conducts pivotal studies for novel FDA OTC Naloxone labeling – work cited as unprecedented by FDA Commissioner
Posted January 18th, 2019. Filed under Concentrics NewsTags: FDA, Naloxone, Pivotal Study
